| Discovery of a novel oral glucocorticoid receptor modulator (AZD9567) with improved side effect profile L Ripa, K Edman, M Dearman, G Edenro, R Hendrickx, V Ullah, ... Journal of Medicinal Chemistry 61 (5), 1785-1799, 2018 | 66 | 2018 |
| Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD C De Savi, RJ Cox, DJ Warner, AR Cook, MR Dickinson, A McDonough, ... Journal of Medicinal Chemistry 57 (11), 4661-4676, 2014 | 32 | 2014 |
| Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators M Hemmerling, K Edman, M Lepistö, A Eriksson, S Ivanova, J Dahmén, ... Bioorganic & Medicinal Chemistry Letters 26 (23), 5741-5748, 2016 | 20 | 2016 |
| Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials TH Myrbäck, S Prothon, K Edman, J Leander, M Hashemi, M Dearman, ... The Lancet Rheumatology 2 (1), e31-e41, 2020 | 16 | 2020 |
| SAT0245 Azd9567: a novel oral selective glucocorticoid receptor modulator, demonstrated to have an improved therapeutic ratio compared to prednisolone in pre-clinical studies … R Hendrickx, T Hegelund-Myrbäck, M Dearman, S Prothon, G Edenro, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 984-985, 2018 | 2 | 2018 |
| Identification of AZD9567, an anti-inflammatory glucocorticoid receptor modulator with improved side effect profile L Ripa, M Dearman, G Edenro, K Edman, R Hendrickx, M Lepisto, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | 1 | 2017 |
| Inhaled bacterial mimetic increases PAD4-dependent NETosis in the lungs T Andreasson, L Odqvist, S Arlbrandt, C Wingren, P Berntsson, M Rhedin, ... European Respiratory Journal 56 (suppl 64), 2020 | | 2020 |
| SAT0251 Selective glucocorticoid receptor modulator shows potent anti-inflammatory effect with improved metabolic profile in a phase i study supported by in vitro data TH Myrbäck, S Prothon, M Dearman, G Edenro, J Leander, M Hashemi, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 987-987, 2018 | | 2018 |
| Next generation glucocorticoid receptor modulators K Edman, G Belfield, M Dearman, G Edenro, S Geschwindner, ... Endocrine Abstracts 54, 2018 | | 2018 |
| Biphasic Granulocytic Inflammation And Bronchoconstriction Towards Serotonin Occurs Detached From Parenchymal Hyperresponsiveness In A Rat Model Of Allergic Asthma B Fuchs, MS Dearman, M Fredberg, A Smailagic, L Swedin B33. GRANULOCYTE ACTIVATION IN LUNG DISEASE, A2757-A2757, 2014 | | 2014 |
| B33 GRANULOCYTE ACTIVATION IN LUNG DISEASE: Biphasic Granulocytic Inflammation And Bronchoconstriction Towards Serotonin Occurs Detached From Parenchymal Hyperresponsiveness In … B Fuchs, MS Dearman, M Fredberg, A Smailagic, L Swedin American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | | 2014 |
| Cellular pathology of allergic airway inflammatory responses to ovalbumin (OVA) following adoptive transfer of CD4+ T lymphocytes to naive rats KJ Escott, M Dearman, M Foster, A Bahl Journal of Allergy and Clinical Immunology 113 (2), S248, 2004 | | 2004 |
| Functional responses to MIP-1 alpha in isolated human peripheral blood eosinophils MS Dearman, J Purdy, ME Leeson, AK Bahl CLINICAL AND EXPERIMENTAL ALLERGY 31 (1), 159-159, 2001 | | 2001 |
